← All organizations

Gilgamesh Pharmaceuticals

For profit

Also known as: Gilgamesh Pharmaceuticals

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Feb 1, 2024

Acquired by AbbVie on Aug 25, 2025

Timeline

2010s

Jan 1, 2019
Gilgamesh Pharmaceuticals— Founded

2020s

Aug 25, 2025
AbbVie— Acquired By

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Recent trials (4)

NCT06309277OfficialPhase 2Feb 1, 2024
NCT06309277Lead sponsorPhase 2Feb 1, 2024
NCT06236880OfficialPhase 2Jan 31, 2024
NCT06236880Lead sponsorPhase 2Jan 31, 2024

Details

Founded: New York, NY, US Jan 1, 2019
Last known activity: Feb 1, 2024